Larimar Therapeutics Inc (LRMR) with a beta value of 0.83 appears to be a promising investment opportunity.
On Tuesday, Larimar Therapeutics Inc (NASDAQ: LRMR) was -2.10% drop from the session before settling in for the closing price of $6.20. A 52-week range